Sponsor
Heinrich-Heine University, Duesseldorf
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Heinrich-Heine University, Duesseldorf appears in 78 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownBiological Determinants and Neural Compensation of Dysphagia in Parkinson's DiseaseNCT07299448 · lead sponsor · 2025-09-01
RECRUITINGGerman Registry of Alzheimer's Disease Treated With Transcranial Pulse StimulationNCT06313944 · lead sponsor · 2025-08-06
RECRUITINGMETABolic Deterioration in HTX Determines OutcomesNCT07372820 · lead sponsor · 2025-07-24
RECRUITINGAI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRINCT06708910 · lead sponsor · 2025-07-18
RECRUITINGAnti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.NCT06823570 · lead sponsor · 2025-04-01
RECRUITINGImpact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate CancerNCT06820333 · lead sponsor · 2025-01-10
RECRUITINGCognitive Performance, Sleep Disturbances and Fatigue in Multiple SclerosisNCT07426991 · lead sponsor · 2024-11-01
RECRUITINGDiagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate CancerNCT06657131 · lead sponsor · 2024-11-01
RECRUITINGTAVR: The Impact of Prothesis Positioning on Valvular and Coronary HemodynamicsNCT06896227 · lead sponsor · 2024-10-22
RECRUITINGMeasuring Silent Disease Progression in Multiple Sclerosis With a Multimodal ApproachNCT06501950 · lead sponsor · 2024-06-20
RECRUITINGStrategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple SclerosisNCT06461481 · lead sponsor · 2024-06-15
RECRUITINGDetermination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)NCT06626386 · lead sponsor · 2024-06-01
RECRUITINGEarly Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)NCT06124586 · lead sponsor · 2024-02-01
RECRUITINGSmart Monitoring Assessing Spasticity-related HealthNCT06937723 · lead sponsor · 2023-10-19
RECRUITINGMitochondrial Substrate Utilization in the Diabetic Human HeartNCT05958706 · lead sponsor · 2021-12-01
RECRUITINGUnderstanding the 'Durable Effect' Concept of B-cell Modulating TherapiesNCT06586177 · lead sponsor · 2021-10-27
RECRUITINGSystemic Organ Communication in STEMINCT03539133 · lead sponsor · 2017-10-18
RECRUITINGScreening, Characterization, and Longitudinal Follow-up of Patients With Cardiac AmyloidosisNCT07577466 · lead sponsor · 2026-06-15
NOT_YET_RECRUITINGRELIEVE METAB StudyNCT07555925 · lead sponsor · 2026-06-01
NOT_YET_RECRUITINGA Study Testing Whether Low-Dose Radiation Could Help the Immune System and Possibly Improve Early-Onset Alzheimer's Disease.NCT07564700 · lead sponsor · 2026-05-15
NOT_YET_RECRUITINGRandomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance ImagingNCT04993508 · lead sponsor · 2026-04-01
NOT_YET_RECRUITINGCOMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)NCT07455097 · lead sponsor · 2026-01-01
ACTIVE_NOT_RECRUITINGIntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.NCT06599424 · lead sponsor · 2023-10-01
UNKNOWNInfluence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative OutcomeNCT05644821 · lead sponsor · 2023-08-01
COMPLETEDComputer-assisted Risk Evaluation in the Early Detection of Psychotic DisordersNCT05813080 · lead sponsor · 2023-05-01
COMPLETEDProstate Cancer Prevention Clinic for Men With Risk of Familial Prostate CancerNCT05681416 · lead sponsor · 2023-02-01
NOT_YET_RECRUITINGSex Related Differences in Cardiac FunctionNCT05796050 · lead sponsor · 2022-02-02
UNKNOWNImmune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineNCT05019248 · lead sponsor · 2020-09-01
UNKNOWNAutonomic Function in COPD and Risk for Atrial FibrillationNCT03871933 · lead sponsor · 2019-03-01
COMPLETEDProspective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate CancerNCT03979573 · lead sponsor · 2017-10-01
UNKNOWNEndothelial Function and Circulating Microparticle in Patients Under LVAD SupportNCT03923413 · lead sponsor · 2017-05-01
COMPLETEDEfficacy of ISST in SchizophreniaNCT02678858 · lead sponsor · 2016-03-01
COMPLETEDAnthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mappingNCT03940625 · lead sponsor · 2015-06-03
COMPLETEDStudy Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided BiopsyNCT02450266 · lead sponsor · 2015-02-01
UNKNOWNMobile Medically Supervised Patient Management in Rheumatoid ArthritisNCT02565225 · lead sponsor · 2014-11-01
COMPLETEDThe Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) PatientsNCT02150473 · lead sponsor · 2014-10-01
TERMINATEDMagnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patients With Shunt or Chronic Obstructive Pulmonary DiseaseNCT02449083 · lead sponsor · 2014-06-01
COMPLETEDCVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart FailureNCT02079259 · lead sponsor · 2013-11-01
COMPLETEDLong-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple SclerosisNCT01755871 · lead sponsor · 2013-01-01
TERMINATEDComparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyNCT01609153 · lead sponsor · 2012-06-01
COMPLETEDA Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA ValuesNCT01553838 · lead sponsor · 2012-01-01
COMPLETEDRandomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate BiopsyNCT02220517 · lead sponsor · 2011-11-01
COMPLETEDCocoa Flavanols and Painfree Walking DistanceNCT01064583 · lead sponsor · 2009-10-01
COMPLETEDSocial Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical TrailNCT00618280 · lead sponsor · 2008-01-01
COMPLETEDCombination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast CancerNCT00309920 · lead sponsor · 2004-01-01
UNKNOWNRepetitive Transcranial Magnetic StimulationNCT00169689 · lead sponsor · 2003-06-01
COMPLETEDThe Effect of a Weight Management Program During Treatment With OlanzapineNCT00169702 · lead sponsor · 2003-06-01
COMPLETEDMaintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode SchizophreniaNCT00159120 · lead sponsor · 2001-11-01
COMPLETEDProdrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode SchizophreniaNCT00159133 · lead sponsor · 2001-11-01
COMPLETEDOne Year Drug Treatment in First-Episode SchizophreniaNCT00159081 · lead sponsor · 2000-11-01
COMPLETEDEarly TIPS in Patients With Liver Cirrhosis and AscitesNCT06576934 · collaborator · 2025-04-01
RECRUITINGHome-based Gait and Balance Training in Patients With Movement DisordersNCT06617884 · collaborator · 2023-01-04
RECRUITINGNational Network Genomic Medicine Lung Cancer, GermanyNCT05934032 · collaborator · 2018-04-01
RECRUITINGStudy on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)NCT06150690 · collaborator · 2012-08-21
RECRUITINGINJECTHEAL - Investigation of Chronic Wound Exudate and BiofilmNCT07745764 · collaborator · 2026-08-01
NOT_YET_RECRUITINGHDV-Europe: Prevalence and Outcome of HDV in HIV/HBV CoinfectionNCT06264583 · collaborator · 2024-05-01
UNKNOWNEvaluation of Remote DBS Programming.NCT05193825 · collaborator · 2022-03-22
COMPLETEDDevelopment and Evaluation of a Web-based Programme on Relapse Management for People With Multiple SclerosisNCT04233970 · collaborator · 2020-02-17
COMPLETEDInteractive Web Platform for EmPOWERment in Early Multiple SclerosisNCT03968172 · collaborator · 2019-07-01
COMPLETEDPostcardiotomy Venoarterial Extracorporeal Membrane OxygenationNCT03508505 · collaborator · 2018-01-01
UNKNOWNDrugs studied in this sponsor's trials
13 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Heinrich-Heine University, Duesseldorf as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
amisulpride2
placebo2
acetylcysteine1
adalimumab1
amantadine1
cyclophosphamide1
dextromethorphan hydrobromide1
docetaxel1
amisulpride RxCUI 46303 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
2 trials
placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
2 trials
acetylcysteine RxCUI 197 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
adalimumab RxCUI 327361 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
amantadine RxCUI 620 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
dextromethorphan hydrobromide RxCUI 102490 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
doxorubicin hydrochloride RxCUI 142433 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
epirubicin hydrochloride RxCUI 203213 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
fingolimod RxCUI 1012892 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
fluorouracil RxCUI 4492 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
olanzapine RxCUI 61381 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor50
collaborator28
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.